| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/09/2013 | CN102861060A Application of Houttuynoid B in leukemia treatment medicine |
| 01/09/2013 | CN102861059A Application of Houttuynoid D in pancreatic cancer treatment medicine |
| 01/09/2013 | CN102861058A Application of Houttuynoid D in cholangiocarcinoma treatment medicine |
| 01/09/2013 | CN102861057A Application of Houttuynoid D in skin cancer treatment medicine |
| 01/09/2013 | CN102861056A Application of Houttuynoid A in endometrial cancer treatment medicine |
| 01/09/2013 | CN102861053A Application of Houttuynoid D in leukemia treating medicine |
| 01/09/2013 | CN102861052A Application of Houttuynoid A in medicine for treating ileocecum cancer |
| 01/09/2013 | CN102861051A Application of Houttuynoid A in medicine for treating renal cancer |
| 01/09/2013 | CN102861050A Application of Houttuynoid A in medicine for treating pancreatic cancer |
| 01/09/2013 | CN102861049A Application of Houttuynoid A in medicine for treating liver cancer |
| 01/09/2013 | CN102861048A Application of Houttuynoid A in medicine for treating nasopharyngeal carcinoma |
| 01/09/2013 | CN102861046A Application of Houttuynoid A in ovarian cancer treatment medicine |
| 01/09/2013 | CN102861023A Application of saringosterol |
| 01/09/2013 | CN102861020A Application of folic acid on preparation of medicine for preventing initial colorectal adenoma |
| 01/09/2013 | CN102860998A New application of taxol and taxol nasal delivery preparation |
| 01/09/2013 | CN102860996A Method for preparing lycoypene microcapsule |
| 01/09/2013 | CN102343100B Method for quickly preparing rutin inclusion compound |
| 01/09/2013 | CN102302491B Application of sorafenib in treatment of cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) |
| 01/09/2013 | CN102283836B Application of sorafenib in treatment of early brain injury (EBI) after subarachnoid hemorrhage (SAH) |
| 01/09/2013 | CN102240303B Production method of composite probiotics for preventing and treating intestinal cancer |
| 01/09/2013 | CN102225183B Chinese traditional medicine composition for treating cancer and its preparation |
| 01/09/2013 | CN102219822B Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof |
| 01/09/2013 | CN102153508B 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs |
| 01/09/2013 | CN102144980B LHRH (luteinizing hormone-releasing hormone antagonist) lyophilized powder injection with improved stability |
| 01/09/2013 | CN102140139B Antitumor human single-chain antibody |
| 01/09/2013 | CN102101879B Arenobufagin space isomer compound and preparation and application thereof |
| 01/09/2013 | CN102040643B Ciclesonide nitrate derivative |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101851256B Ruthenium (II) porphyrin complex connected by flexible carbon chain and preparation method and application thereof |
| 01/09/2013 | CN101838201B Phenol compounds and application thereof |
| 01/09/2013 | CN101787078B Collagen polypeptide, preparation method and application thereof |
| 01/09/2013 | CN101781353B 20(S)-ginsenoside Rh2 derivatives for regulating and controlling ER Alpha/ER Beta-TNF Alpha channel as well as preparation and anti-tumor application thereof |
| 01/09/2013 | CN101745089B Medicament for treating stomach cancer and preparation method thereof |
| 01/09/2013 | CN101636411B Interferon alpha 2a modified by polyethylene glycol, synthesis process and application thereof |
| 01/09/2013 | CN101596320B Medicament for treating tumor and application thereof |
| 01/09/2013 | CN101591396B Anti-erbB2 human antibody MIL-5 and application thereof |
| 01/09/2013 | CN101522645B Phenyl derivatives and their use as immunomodulators |
| 01/09/2013 | CN101374515B Akt活性抑制剂 Akt activity inhibitor |
| 01/09/2013 | CN101268095B Bifunctional protein anchors |
| 01/09/2013 | CN101228151B Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidine-2-ylamino)-benzamide |
| 01/09/2013 | CN101146791B 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors |
| 01/09/2013 | CN101124318B Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 01/08/2013 | US8350076 Sodium channel blockers |
| 01/08/2013 | US8350016 Oligonucleotide compositions and their use to induce apoptosis |
| 01/08/2013 | US8350008 WISP polypeptides and nucleic acids encoding same |
| 01/08/2013 | US8349888 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 01/08/2013 | US8349853 Detection defect in gene expression of hedgehog gene; diagnosis of cancer |
| 01/08/2013 | US8349836 Phthalazine derivatives as inhibitors of protein kinase |
| 01/08/2013 | US8349832 Compounds and compositions for treating cancer |
| 01/08/2013 | US8349827 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds |
| 01/08/2013 | US8349798 Caveolin peptides and their use as therapeutics |
| 01/08/2013 | US8349606 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 01/08/2013 | US8349374 Inhibition of angiogenesis and destruction of angiogenic vessels with extracts of noni juice (Morinda citrifolia) |
| 01/08/2013 | CA2710224C Novel dihydroindolone derivatives, method for production thereof and pharmaceutical compositions comprising said derivatives |
| 01/08/2013 | CA2677315C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/08/2013 | CA2677176C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 01/08/2013 | CA2660760C Fluoroalkoxycombretastatin derivatives, methods for producing same and use thereof |
| 01/08/2013 | CA2653941C Substituted amino purine derivatives and uses thereof |
| 01/08/2013 | CA2642665C Anti-cancer pharmaceutical composition |
| 01/08/2013 | CA2606156C Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 01/08/2013 | CA2600276C Polyphenol coxib combinations and methods |
| 01/08/2013 | CA2565968C Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 01/08/2013 | CA2565013C Method for producing pentacyclic taxans |
| 01/08/2013 | CA2543982C Antibodies that bind interleukin-4 receptor |
| 01/08/2013 | CA2513260C Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 01/08/2013 | CA2510337C Topoisomerase-targeting agents |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2466148C Medical compositions for intravesical treatment of bladder cancer |
| 01/08/2013 | CA2457541C Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 01/08/2013 | CA2390095C Method and system to remove cytokine inhibitor in patients |
| 01/08/2013 | CA2388337C Method of inducing and/or enhancing an immune response to tumor antigens |
| 01/08/2013 | CA2377207C Combinations for introducing nucleic acids into cells |
| 01/08/2013 | CA2341777C Neutral amino acid transporter and gene thereof |
| 01/08/2013 | CA2305681C Apoptosis-related compounds and their use |
| 01/08/2013 | CA2299630C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 01/03/2013 | WO2013003697A1 Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
| 01/03/2013 | WO2013003641A2 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013003557A1 Photoactivatable receptors and their uses |
| 01/03/2013 | WO2013003307A1 2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 01/03/2013 | WO2013003112A1 Methods and compositions for treatment of cancer and autoimmune disease |
| 01/03/2013 | WO2013002733A1 Pharmaceutical compositions for treating cancer |
| 01/03/2013 | WO2013002636A1 Controlled release system |
| 01/03/2013 | WO2013002364A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |
| 01/03/2013 | WO2013001372A2 Methods and compositions for inhibition of activation of regulatory t cells |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | WO2013001167A1 Non-toxic compositions for decreasing the risk of cancer caused by oral microbes |
| 01/03/2013 | WO2013001080A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | WO2013000543A1 Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | WO2013000286A1 Bufogenin derivatives, preparation methods, compositions containing such derivatives and uses thereof |
| 01/03/2013 | WO2013000269A1 Camptothecin derivative, method for preparing same, pharmaceutical composition and use thereof |
| 01/03/2013 | WO2013000234A1 A novel recomnimant bifunctional fusion protein and its preparation and use |
| 01/03/2013 | WO2013000054A1 Method for producing pterocarpans, cytomodulating composition containing pterocarpans, and use of pterocarpans |
| 01/03/2013 | WO2012154942A3 Ceramide anionic liposome compositions |
| 01/03/2013 | WO2012151141A3 A facile preparation of 4-substituted quinazolines and related heterocycles |